cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Twist Bioscience Corp
19 own
14 watching
Current Price
$25.31
$-5.59
(-18.09%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
1,430.6M
52-Week High
52-Week High
66.15
52-Week Low
52-Week Low
21.78
Average Volume
Average Volume
3.28M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization1,430.6M
icon52-Week High66.15
icon52-Week Low21.78
iconAverage Volume3.28M
iconDividend Yield--
iconP/E Ratio--
What does the Twist Bioscience Corp do?
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. Twist Bioscience Corporation has a collaboration agreement with Pandion Therapeutics, Inc. to apply its antibody optimization platform for a targeting arm of a bispecific antibody. The company was founded in 2013 and is headquartered in San Francisco, California.
Read More
How much money does Twist Bioscience Corp make?
News & Events about Twist Bioscience Corp.
PR Newswire
9hours ago
TWIST BIOSCIENCE SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Twist Bioscience Corporation - TWST TWIST BIOSCIENCE SHAREHOLDER ALERT BY FORMER...
Globe Newswire
10hours ago
NEW YORK, Feb. 03, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of NewAge, Inc. (OTC: NBEVQ), Twist Bioscience Corp (NASDAQ: TWST), Sunlight Financial ...
Globe Newswire
1day ago
LOS ANGELES, Feb. 03, 2023 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (GPM) reminds investors of the upcomingFebruary 10, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Twist Bioscience Corporation (Twist or the...
Business Wire
1day ago
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today reported financial results and business highlights for the first quarter of fiscal 2023 ended December 31, 2022. 'We had a...
PR Newswire
1day ago
TWST SHAREHOLDER ALERT: Jakubowitz Law Reminds Twist Shareholders of a Lead Plaintiff Deadline of February 10, 2023 TWST SHAREHOLDER ALERT: Jakubowitz Law Reminds Twist Shareholders of a Lead Plaintiff Deadline of February 10, 2023 PR Newswire NEW YORK, Feb. 3, 2023 NEW YORK, Feb. 3, 2023...
Frequently Asked Questions
Frequently Asked Questions
What is Twist Bioscience Corp share price today?
plus_minus_icon
Can Indians buy Twist Bioscience Corp shares?
plus_minus_icon
How can I buy Twist Bioscience Corp shares from India?
plus_minus_icon
Can Fractional shares of Twist Bioscience Corp be purchased?
plus_minus_icon
What are the documents required to start investing in Twist Bioscience Corp stocks?
plus_minus_icon
What is today’s traded volume of Twist Bioscience Corp?
plus_minus_icon
What is today’s market capitalisation of Twist Bioscience Corp?
plus_minus_icon
What is the 52-Week High and Low Range of Twist Bioscience Corp?
plus_minus_icon
What percentage is Twist Bioscience Corp down from its 52-Week High?
plus_minus_icon
What percentage is Twist Bioscience Corp up from its 52-Week Low?
plus_minus_icon
Current Price
$25.31
$-5.59
(-18.09%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00